Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

China approves AstraZeneca’s Forxiga for heart failure

pharmaceutical-technologyFebruary 07, 2021

Tag: AstraZeneca , Forxiga , Heart failure , china , NMPA

PharmaSources Customer Service